StemBioSys' Series B Round

StemBioSys raised a round of funding on May 16, 2018.

StemBioSys manufactures and develops stem cell technologies to meet the promise of regenerative medicine in a surging global market. The company's technologies can isolate large numbers of highly plur…

Articles about StemBioSys' Series B Round: